Biomechanical engineering

CHOP Researchers Comprehensively Assess the Safety of Using Your Head in Youth Soccer

Retrieved on: 
Wednesday, May 24, 2023

PHILADELPHIA, May 24, 2023 /PRNewswire/ -- Repeatedly heading a soccer ball has been previously associated with negative long-term brain health for professional players. However, in a new study from researchers at the Minds Matter Concussion Program at Children's Hospital of Philadelphia (CHOP), a small number of repeated soccer headers equivalent to a throw-in did not cause immediate neurophysiological deficits for teens, suggesting that limited soccer heading exposure in youth sports may not result in irreversible harm if players are properly trained.

Key Points: 
  • The findings, which represent the most comprehensive real-time study of soccer headers in adolescent athletes, were published in the Journal of Biomechanical Engineering .
  • For some professional athletes, repeated head loading in sports – using your head as part of the game – is associated with negative long-term brain health even when there are no initial clinical symptoms.
  • Despite the awareness of long-term consequences, short-term neurophysiological issues after repeated head impacts like soccer heading are poorly understood in youth athletes.
  • The study did not assess the safety of regular soccer headers over the course of a season or scholastic career.

Azin Parhizgar To Chair Protembis’ New Board of Directors

Retrieved on: 
Thursday, September 15, 2022

Protembis GmbH , a privately-held emerging cardiovascular medical device company, announced today the appointment of highly experienced and successful serial entrepreneur and medical device executive Azin Parhizgar (Ph.D.) as an Independent Member and Chairwoman of the Board of Directors.

Key Points: 
  • Protembis GmbH , a privately-held emerging cardiovascular medical device company, announced today the appointment of highly experienced and successful serial entrepreneur and medical device executive Azin Parhizgar (Ph.D.) as an Independent Member and Chairwoman of the Board of Directors.
  • Prior to Claret Medical, Azin served as the COO of Conor Medsystems, which led to the acquisition of the company by Johnson & Johnson.
  • It is both exciting and an honor for us that Azin has chosen to lead our Board of Directors as new Chairwoman, said Karl von Mangoldt and Conrad Rasmus, Co-CEOs of Protembis.
  • I am convinced that there is a need for a simple and effective next generation complete cerebral protection system notes Azin Parhizgar.

Taking Workplace Safety Head On: First-of-its-Kind WaveCel Hard Hat Strives to Give Workers Better Protection Against Traumatic Brain Injury

Retrieved on: 
Thursday, March 3, 2022

Today, WaveCel announces a new line of hard hats created to better protect workers against traumatic brain injury (TBI), one of the leading workplace injuries as a result of slips, falls and strikes to the head by falling or moving objects.

Key Points: 
  • Today, WaveCel announces a new line of hard hats created to better protect workers against traumatic brain injury (TBI), one of the leading workplace injuries as a result of slips, falls and strikes to the head by falling or moving objects.
  • The WaveCel hard hat is designed for various industries, including construction, engineering, manufacturing, aerospace, mining, gas, oil and forestry.
  • "The WaveCel hard hat has been meticulously tested and strategically designed to ensure an increase in safety of employees working in environments where risk of TBI is high."
  • Providing the same unprecedented level of protection, there are two different models of the WaveCel hard hat the WaveCel T2+ PRO and the WaveCel T2+ MAX.

CroíValve Raises an €8M Series A Round to Support a Feasibility Clinical Study

Retrieved on: 
Monday, February 7, 2022

CroValve, a Dublin based medical device company developing a novel treatment for tricuspid regurgitation, has raised a Series A round to fund a Feasibility clinical study with its DUO Coaptation Valve system.

Key Points: 
  • CroValve, a Dublin based medical device company developing a novel treatment for tricuspid regurgitation, has raised a Series A round to fund a Feasibility clinical study with its DUO Coaptation Valve system.
  • Additionally, CroValve welcomes Dr. Azin Parhizgar, Ph.D., a leading medical device entrepreneur in structural heart, to its Board of Directors.
  • In addition, Helen Scotch has joined the Senior Leadership Team as Vice President of Clinical and Regulatory Affairs.
  • The funding will support a European Feasibility Study of the CroValve Transcatheter Tricuspid DUO Coaptation Valve System.